Yang Zhao is an accomplished professional in the field of antibody discovery and engineering, currently serving as the Director at Dianthus Therapeutics, Inc. Previous roles include Director and Associate Director at Viridian Therapeutics, Inc., Principal Scientist at KSQ Therapeutics, Inc., and Senior Scientist at EMD Serono, Inc. Additionally, Yang Zhao gained valuable experience as a Postdoctoral Fellow at the Howard Hughes Medical Institute at Yale University.